Related Experiment Video

Updated: Oct 17, 2025

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.1K

Study on clinical response and predictive indexes of therapeutic effect of interferon on chronic hepatitis B

Yang Zhang1, Na Liang2, Mei Zhang3

  • 1Department of Infection Liver Disease, Zaozhuang Municipal Hospital, Zaozhuang, China.

Minerva Medica
|October 11, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.5K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.0K

Related Experiment Videos

Last Updated: Oct 17, 2025

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.1K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.5K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.0K

Related Concept Videos

Therapeutic Index01:13

Therapeutic Index

5.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

26
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
26

Articles linked to this work by shared authors, journal, and citation graph.

Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B.

Clinical rheumatology·2026

Perp Deficiency Induces Defective Negative Selection and Autoimmune Arthritis in Aged Mice.

Aging cell·2026

T cell-inspired therapeutic delivery platforms: From nanomedicines to cell therapy.

Materials today. Bio·2026

Design of a Dual-Detection System for SERRS Cytokine Detection in the NIR Region Simultaneously Matched with Particles and Signal Molecules.

Analytical chemistry·2026

Comparative risk of tuberculosis infection with different TNF-α inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis.

Frontiers in immunology·2026

Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 study.

Rheumatology (Oxford, England)·2026

Co-occurrence of sleep disturbances and perceived stress in law enforcement personnel: a systematic review and meta-analysis.

Minerva medica·2026

Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities.

Minerva medica·2026

Celiac disease incidence after COVID-19 infection.

Minerva medica·2026

A phase III, randomized, double blind, controlled trial to evaluate the efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg, compared to diclofenac 75 mg monotherapy and placebo, in the treatment of acute low back pain.

Minerva medica·2026

Effects of GLP1-RAs and SGLT2i on liver steatosis and fibrosis in MASLD with type 2 diabetes.

Minerva medica·2026

Diagnostic accuracy of the Gugging Swallowing Screen and exploratory submental ultrasonographic findings in dysphagia screening for Parkinson disease: a retrospective cross-sectional study using videofluoroscopy as reference standard.

Minerva medica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us